Skyhawk Therapeutics | Finanzwire

Basculer en Français

9756	Companies
194927	Keywords
125963	Articles
103651	Press releases

Home
Companies
Skyhawk Therapeutics

BRIEF

published on 01/27/2026 at 14:10, 3 hours 45 minutes ago

Skyhawk Therapeutics Reports Interim Phase 1 Results for Huntington's Treatment SKY-0515

Phase 1 Clinical Trial Interim Results Huntington's Disease Skyhawk Therapeutics SKY-0515
PRESS RELEASE

published on 01/27/2026 at 14:05, 3 hours 50 minutes ago

Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease
Skyhawk Therapeutics reports positive interim results in Phase 1 Clinical Trial of SKY-0515 for Huntington's Disease, showing promising data on disease progression and safety

Biotechnology Clinical Trial Huntington's Disease Skyhawk Therapeutics SKY-0515

Accesswire

Published on 01/27/2026 at 15:00, 2 hours 55 minutes ago

MicroVision Announces Agreement to Acquire Luminar Assets to Accelerate Commercial Strategy and Expand Product Portfolio
Published on 01/27/2026 at 14:45, 3 hours 10 minutes ago

Organto Announces Appointment of Chad Hagen to the Board of Directors
Published on 01/27/2026 at 14:30, 3 hours 25 minutes ago

NV Gold Announces Non-Brokered Private Placement
Published on 01/27/2026 at 14:23, 3 hours 32 minutes ago

Worksport Subsidiary Terravis Energy Selects Major Asian Manufacturing Partner for Breakthrough Zerofrost(TM) Heat Pump; Announces Path to Commercialization Within 2026
Published on 01/27/2026 at 14:15, 3 hours 40 minutes ago

Terravis Energy Secures Mass Manufacturing for No-Defrost Heat Pump Amid North American Polar Vortex Crisis

View all ACCESSWIRE

EQS Group

Published on 01/27/2026 at 17:45, 10 minutes ago

Linedata Services: 2025 revenue: €169.6m (-7.7%)
Published on 01/27/2026 at 17:40, 15 minutes ago

VALBIOTIS SA: 2025 Commercial roll-out underway, reflected in a strong ramp-up in revenues in Q4
Published on 01/27/2026 at 16:43, 1 hour 11 minutes ago

MHH to Present Scientific Findings on Cold Plasma Therapy for Pulmonary Application at Press Conference in February 2026
Published on 01/27/2026 at 16:16, 1 hour 39 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Dauch Corporation
Published on 01/27/2026 at 16:03, 1 hour 52 minutes ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc

Les Echos

Published on 01/27/2026 at 17:50, 5 minutes ago

CDA - Q1 2025 2026 sales
Published on 01/27/2026 at 17:45, 10 minutes ago

Imerys-27-01-2026-information-share-capital-and-voting-rights-as-of-31-December-2025
Published on 01/27/2026 at 17:40, 15 minutes ago

Mersen: Change to the Board of Directors
Published on 01/27/2026 at 14:05, 3 hours 50 minutes ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010167296
Published on 01/27/2026 at 14:01, 3 hours 53 minutes ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010167247

View all LES ECHOS COMFI WIRE